MHRA approves Pfizer’s Velsipity to treat people with ulcerative colitis
Studies showed that 26% of those who received the once-daily tablet achieved clinical remission after 12 weeks of treatment. Â Â
American pharmaceutical giant Pfizer has...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.